Overview

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate whether intravenous ciprofloxacin is as effective as cefepime for the initial treatment of febrile neutropenia developed in patients with hematologic diseases.
Phase:
Phase 3
Details
Lead Sponsor:
Center for Supporting Hematology-Oncology Trials
Collaborator:
Bayer
Treatments:
Cefepime
Cephalosporins
Ciprofloxacin